Dendrite Clinical Systems is delighted to report that our Managing Director, Dr Peter Walton, has published a chapter discussing the value of clinical registries in new publication on Laparoscopic Sleeve Gastrectomy (LSG). In his Chapter, Dr Peter Walton outlines value of national bariatric registries and their capability to deliver evidence on a global basis, as well as providing some practical perspectives on best practice when setting out to start a national registry and how to keep a good registry going.
Dendrite Clinical Systems and the Institute for Health Research (IGES) in Berlin, Germany, have initiated the Outpatient Treatment of COVID-19 Infections (ABC-19) study, to record data on the treatment of COVID-19 patients and discover more about the outpatient course of the disease, the individual risk factors of patients that contribute to severe COVID-19 courses and the procedures of general practitioners (GPs).
Researchers at the University College London and University College London Hospitals NHS Foundation Trust), London, UK, have reported that the vast majority of participants with new onset loss of smell were positive for COVID19, and this acute loss of sense of smell needs to be considered globally as a criterion for self-isolation, testing and contact tracing in order to contain the spread of COVID-19.
Dendrite Clinical Systems’ innovative “Intellect Web” software has been chosen by an international group of 17 leading diabetes experts from the multidisciplinary Diabetes Surgery Summit (DSS), as the platform on which the CoviDiab project will establish a Global Registry to collect new cases of diabetes in patients with COVID-19.
“I am very pleased to report that demand for the Dendrite Web-Registry platform has reached an all-time high” Dr Peter Walton, Managing Director of Dendrite Clinical System. “We’re receiving new orders for new national and international registries every few days now – for surgical registries, medical registries, rare disease registries, medical device registries and Coronavirus Registries (for a range of Community, National, International and Global Covid-19 Registries).”
“Over 90% of our new web-registry orders include our innovative e-PROMS module that enables patients to enter data into registries remotely”. The automated e-PROMS module can automatically send (at designated time intervals) a secure personalised message to appropriately consented patients and they can complete a PROMS questionnaire on their smart-phones, iPads or computers anywhere in the world (provided they have Internet access) and when completed, the data returns automatically to the registry.
“We have instituted over 35 different PROMS instruments ranging from generic outcome Euroqol EQ-5D type questionnaires, to a very wide range of disease or treatment specific PROMS instruments such as the Breast Q for breast reconstruction with DIEP/SIEA flap, the Atrial Fibrillation Severity Score and the Multiple Sclerosis Quality of Life MSQoL-54 questionnaire,” Dr Walton added. “A great benefit of our e-PROMS module is that essentially the patient is doing the work of data collection and the data just streams in. The e-PROMS module is guaranteed to provide safe and secure patient data collection, and we look forward to working with all our current and future customers to help them develop and expand PROMS data collection.”
Patient Reported Outcome Measures (PROMs) are standardised, validated instruments or questionnaires that are completed by patients to measure their perception of their functional well-being and health status, and patients rate their health by scoring the severity or difficulty in completing certain tasks or routine activities. Dendrite’s flexible innovative e-PROMS module can be adapted include bespoke instruments across the whole spectrum of clinical scenarios, whilst maintaining patient anonymity and confidentiality, ensuring data validation, increasing efficiency and simplifying the data collection process).
